You Position: Home > Paper
胰腺癌恶病质的营养支持治疗进展
( views:0, downloads:0 )
- Author:
- No author available
- Journal Title:
- Chinese Journal of Pancreatology
- Issue:
- 4
- DOI:
- 10.3760/cma.j.cn115667-20190919-00082
- Key Word:
- 胰腺癌;恶病质;营养支持;综述
Abstract： 胰腺癌与恶病质之间关系密切，恶病质显著影响患者的生存期及生存质量。积极地营养支持是治疗胰腺癌恶病质的重要手段，可使多数患者获益。
- [1]Saito, Tomotaka,Hirano, Kenji,Isayama, Hiroyuki,etc.The Role of Pancreatic Enzyme Replacement Therapy in Unresectable Pancreatic Cancer A Prospective Cohort Study[J].2017,46(3).
- [2]Werner Kristin,Küllenberg de Gaudry Daniela,Taylor Lenka A.,etc.Dietary supplementation with n-3-fatty acids in patients with pancreatic cancer and cachexia: marine phospholipids versus fish oil - a randomized controlled double-blind trial[J].2017,16(1).
- [3]Hae-Yun, Chung,Yoo Kyoung, Park.Rationale, Feasibility and Acceptability of Ketogenic Diet for Cancer Treatment.[J].2017,22(3).
- [4]Behnam Ebrahimi,Susan L. Tucker,Donghui Li,etc.Cytokines in pancreatic carcinoma: Correlation with phenotypic characteristics and prognosis[J].2004,101(12).
- [5]Kentaro, Nakamura,Hidekazu, Tonouchi,Akina, Sasayama,etc.A Ketogenic Formula Prevents Tumor Progression and Cancer Cachexia by Attenuating Systemic Inflammation in Colon 26 Tumor-Bearing Mice.[J].2018,10(2).
- [6]Janine, Krüger,Peter J, Meffert,Lena J, Vogt,etc.Early Parenteral Nutrition in Patients with Biliopancreatic Mass Lesions, a Prospective, Randomized Intervention Trial.[J].2016,(11).
- [7]Paolo Cotogni,Luca De Carli,Roberto Passera,etc.Longitudinal study of quality of life in advanced cancer patients on home parenteral nutrition[J].2017,6(7).
- [8]Eley HL,Tisdale MJ,Russell ST.Effect of branched-chain amino acids on muscle atrophy in cancer cachexia[J].2007,407(1).
- [9]Zaira, Aversa,Andrea, Bonetto,Paola, Costelli,etc.β-hydroxy-β-methylbutyrate (HMB) attenuates muscle and body weight loss in experimental cancer cachexia.[J].2011,38(3).
- [10]Cariuk P,Lorite MJ,Todorov PT,etc.Induction of cachexia in mice by a product isolated from the urine of cachectic cancer patients[J].1997.
- [11]Tara C Mueller,Marc A Burmeister,Jeannine Bachmann,etc.Cachexia and pancreatic cancer: Are there treatment options?[J].2014,(28).
- [12]Kyohei, Abe,Tadashi, Uwagawa,Koichiro, Haruki,etc.Effects of ω-3 Fatty Acid Supplementation in Patients with Bile Duct or Pancreatic Cancer Undergoing Chemotherapy.[J].2018,38(4).
- [13]Greetje, Vanhoutte,Mick, van de Wiel,Kristin, Wouters,etc.Cachexia in cancer: what is in the definition?[J].2016,(1).
- [14]Sirois, Jacinthe,Murphy, Jessica,Gagnon, Bruno,etc.Identification of neutrophil-derived proteases and angiotensin II as biomarkers of cancer cachexia[J].2016,114(6).
- [15]Garcia Luna P P,Garcia Peris P,Zarazaga A,etc.n-3 Fatty acids, cancer and cachexia: a systematic review of the literature.[J].2007,97(5).
- [16]Dev, Rony,Wong, Angelique,Hui, David,etc.The Evolving Approach to Management of Cancer Cachexia[J].2017,31(1).
- [17]Robert W, Jackman,Jess, Floro,Rei, Yoshimine,etc.Continuous Release of Tumor-Derived Factors Improves the Modeling of Cachexia in Muscle Cell Culture.[J].2017,8(Spec ).
- [18]Tora S. Solheim,Barry J.A. Laird,Trude Rakel Balstad,etc.A randomized phase II feasibility trial of a multimodal intervention for the management of cachexia in lung and pancreatic cancer[J].2017,8(5).
- [19]Miller, Kimberly D.,Siegel, Rebecca L.,Lin, Chun Chieh,etc.Cancer treatment and survivorship statistics, 2016[J].2016,66(4).
- [20].Cancer-associated cachexia.[J].2018,4(Spec).
- [21]Fearon,K.C.H.,Guttridge,D.C.,Glass,D.J..Cancer cachexia: Mediators, signaling, and metabolic pathways[J].2012,16(2).
- [22]Asta Bye,Marit S Jordh?y,Grete Skjegstad,etc.Symptoms in advanced pancreatic cancer are of importance for energy intake.[J].2013,21(1).
- [23]Surendra K, Shukla,Teklab, Gebregiworgis,Vinee, Purohit,etc.Metabolic reprogramming induced by ketone bodies diminishes pancreatic cancer cachexia.[J].2014,2.
- [24]Satish,Patel,Anna,Alvarez-Guaita,Audrey,Melvin,etc.GDF15 Provides an Endocrine Signal of Nutritional Stress in Mice and Humans.[J].2019,29(3).